Featured
-
-
Article
| Open Access
Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population
A modelled evaluation of screening and treatment strategies for prevention of cervical cancer in 78 low- and lower-middle-income countries provides evidence to support the World Health Organization’s recommendation of primary HPV testing for women in the general population.
- Kate T. Simms
- , Adam Keane
- & Karen Canfell
-
Correspondence |
An EU task force to assess the burden of rare diseases
- Pavel Kolkhir
- , Diana Alecsandra Grad
- & Juanita Haagsma
-
-
Correspondence |
A randomized controlled trial to test financial incentives for COVID-19 vaccination in Ghana
- Raymond Duch
- , Edward Asiedu
- & Philip Clarke
-
Comment |
Cancer treatments should benefit patients: a common-sense revolution in oncology
Many newly approved cancer therapeutics offer limited clinical benefits yet are still prescribed to patients. A common-sense revolution in oncology would prioritize treatments that meaningfully improve survival and quality of life.
- Bishal Gyawali
- & Christopher M. Booth
-
Correspondence |
Building a pandemic supply chain — equity over equality
- Vivian Yee
- , Simar Singh Bajaj
- & Fatima Cody Stanford
-
Article
| Open Access
Effects of a large-scale social media advertising campaign on holiday travel and COVID-19 infections: a cluster randomized controlled trial
A new cluster randomized controlled trial conducted in 13 American states demonstrates that a social media advertising campaign using videos of healthcare professionals to encourage users to stay at home over the holiday season was effective in reducing travel and subsequent spread of COVID-19.
- Emily Breza
- , Fatima Cody Stanford
- & Esther Duflo
-
Correspondence |
Public opinion on global rollout of COVID-19 vaccines
- Philip M. Clarke
- , Laurence S. J. Roope
- & Raymond Duch
-
Perspective |
Toward universal health coverage in the post-COVID-19 era
All countries worldwide have signed up to the United Nations Sustainable Development Goals and committed to the objective of achieving universal health coverage. Getting there will require understanding how packages of essential health services can be developed in resource-constrained settings and how experts and the public can make decisions about which health services should be provided free of charge.
- Stéphane Verguet
- , Alemayehu Hailu
- & Ole Frithjof Norheim
-
Editorial |
Vouching for access
The US Food and Drug Administration's priority review voucher system for drugs to treat neglected disease has come under scrutiny for lacking preconditions that ensure fair pricing of the products that they aim to usher forward. That loophole needs to be closed.
-
Opinion |
Use the Bayh-Dole Act to lower drug prices for government healthcare programs
As drug prices have increased, there is also greater pressure to find ways to ensure access to medicines. An existing provision of the Bayh-Dole Act could help to lower costs for qualifying drugs in federal programs such as Medicare and Medicaid.
- Alfred B Engelberg
- & Aaron S Kesselheim
-
-
-
Warren joins lawmakers proposing new ideas for science funding
Arrests reveal debate about costs and benefits of proton therapy
Mystery disease sleuthing grows—with and without NIH funding